|
|||||
|
|
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity |
|
| Authors: | Benjamin E. Onderdonk MD MS Paige L. Dorn MD Carlos Martinez PhD Fauzia Arif MBBS Denise Cloutier RN Tatjana Antic MD Daniel W. Golden MD MHPE Theodore Karrison PhD Sean P. Pitroda MD Russell Z. Szmulewitz MD Stanley L. Liauw MD |
| Affiliation: | 1. Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois;2. Rose Medical Center Radiation Oncology, Denver, Colorado;3. Department of Pathology, University of Chicago Medicine, Chicago, Illinois;4. Department of Biostatistics, University of Chicago Medicine, Chicago, Illinois;5. Department of Medicine, University of Chicago Medicine, Chicago, Illinois |
| Abstract: | |
| Keywords: | 5-α-reductase inhibitor (5-ARI) comorbidity dutasteride finasteride luteinizing hormone-releasing hormone prostate cancer |